✦ LIBER ✦

Age, treatment, and outcomes in high-risk non‐ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial

✍ Scribed by Lopes, Renato D.; White, Jennifer A.; Tricoci, Pierluigi; White, Harvey D.; Armstrong, Paul W.; Braunwald, Eugene; Giugliano, Robert P.; Harrington, Robert A.; Lewis, Basil S.; Brogan, Gerard X.; Gibson, C. Michael; Califf, Robert M.; Newby, L. Kristin

Book ID: 123567342
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 594 KB
Volume: 167
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2012.06.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiographic Outcomes With Early Eptifib

Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)

✍ Kunadian, Vijay; Giugliano, Robert P.; Newby, L. Kristin; Zorkun, Cafer; Guo, Ji 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 606 KB

Routine early eptifibatide versus delaye

Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non–ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome trial

✍ Bagai, Akshay; White, Jennifer A.; Lokhnygina, Yuliya; Giugliano, Robert P.; Van 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Racial Differences Among High-Risk Patie

Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial)

✍ Melvin R. Echols; Kenneth W. Mahaffey; Anindita Banerjee; Karen S. Pieper; Amand 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Predictors of high-risk angiographic fin

Predictors of high-risk angiographic findings in patients with non-ST-segment elevation acute coronary syndrome

✍ Beigel, Roy; Matetzky, Shlomi; Gavrielov-Yusim, Natalie; Fefer, Paul; Gottlieb, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 927 KB

The Early Glycoprotein IIb/IIIa Inhibiti

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Relationship between renal function and

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY

✍ Sarah A. Spinler; Kenneth W. Mahaffey; Dianne Gallup; Glenn N. Levine; James J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 286 KB